• SENSEX 77,219.65
    301.80 (+0.39%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,824.90 1,878.00(%)
  • Reliance Industries
    1,318.95 1,611.20(%)
  • Bharti Airtel
    2,042.90 1,726.05(%)
  • SBI Life Insuran
    1,706.80 2,132.90(%)
  • Saregama India
    647.20 574.85(%)
  • Aster DM Quality
    728.05 890.95(%)
  • Multi Comm. Exc.
    3,252.50 1,761.43(%)
  • Jio Platforms
    1,420.50 1,356.40(%)
  • Shree Cement
    24,342.85 28,306.45(%)
  • SFC Enviro.
    397.60 354.05(%)
  • HDFC Bank
    741.00 1,017.90(%)
  • Global Health
    1,422.10 1,542.00(%)
  • BLS Polymers
    255.60 225.00(%)
  • J K Cements
    5,048.20 4,670.05(%)
  • Info Edg.(India)
    1,159.40 909.20(%)
  • ITC
    283.50 421.70(%)
  • SBI
    987.75 1,234.80(%)
  • M & M
    2,948.55 3,840.00(%)
  • Fractal Analyt.
    844.40 1,119.60(%)
  • TBO Tek
    1,522.00 1,005.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Medico Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71781.0
  • ISIN : INE630Y01024
18.79 0 (-0.42%)
  • As on 04 Nov 2026 (EOD)

  • Today’s Low

    18.70

  • Today’s High

    19.43

  • Open

    19.30

  • Perv Close

    18.87

  • 52W Low

    18.36

  • 52W High

    56.88

Key Indicators

  • P/E(TTM)

    11.34

  • Mar.Cap (₹Cr.)

    155.93

  • Div & Yield %

    0.00

  • Book Value(₹)

    9.10

  • Debt-Equity Ratio

    -0.42

  • AGM Date

    03-Nov-2026

  • EPS

    1.66

  • P/E Ratio

    11.34

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    155.93

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.60

  • BV (₹)

    9.10

  • Sales( ₹ in Cr.)

    206.38

  • NP (in Cr.)

    13.10

  • NP Var(%)

    30.0

  • Div%

    0.0

  • CPS (₹)

    2.00

  • EPS (₹)

    1.60

  • Traded Value (₹ in Lakhs)

    156.18

  • 52 Week High

    56.88

  • 52 Week Low

    18.36

  • Price BSE

    19.0

  • Price NSE

    19.00

  • Market Capital( in Cr.)

    156.18

  • P/C Ratio

    9.70

  • P/E Ratio

    12.00

  • Price Vs.BV

    1.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 206.38 150.94 144.92 140.44 121.02 122.39
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 206.38 150.94 144.92 140.44 121.02 122.39
Other Income 5.93 2.69 2.13 3.95 2.03 1.03
Stock Adjustments 1.67 5.16 -2.04 1.18 0.26 -1.54
Total Income 213.98 158.79 145.01 145.57 123.31 121.88
EXPENDITURE :            
Raw Materials 153.00 113.49 107.87 106.05 87.55 90.69
Power and Fuel Cost 3.67 2.92 2.55 2.47 2.29 1.91
Employee Cost 5.71 4.70 5.92 5.68 5.41 4.50
Other Manufacturing Expenses 11.02 7.72 6.25 5.48 6.44 5.25
Selling and Administration Expenses 16.58 12.41 6.49 11.92 11.20 10.60
Miscellaneous Expenses 1.04 -0.15 0.89 0.40 1.05 2.66
Employee Benefit Expenses 5.71 4.70 5.92 5.68 5.41 4.50
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 191.02 141.10 129.97 132.00 113.95 115.61
Operating Profit 22.96 17.69 15.03 13.57 9.36 6.27
Interest 1.81 1.16 0.82 0.75 0.66 0.92
Gross Profit 21.15 16.53 14.21 12.82 8.70 5.35
Depreciation 3.09 3.03 2.88 2.72 2.22 1.65
Profit Before Tax 18.06 13.50 11.33 10.10 6.48 3.70
Current Tax 4.89 3.42 3.17 2.50 1.79 1.06
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.06 -0.01 -0.12 0.36 -0.12 0.05
Reported Net Profit 13.12 10.09 8.29 7.24 4.81 2.59
Extraordinary Items 0.01 0.00 0.00 0.00 -0.03 0.00
Adjusted Net Profit 13.11 10.09 8.29 7.24 4.84 2.59
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 42.30 32.21 23.92 16.67 11.86 9.91
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 55.42 42.30 32.21 23.92 16.67 12.50
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.58 1.22 1.00 0.87 2.90 6.24
Earnings Per Share(Adj)-Unit Curr 1.58 1.22 1.00 0.87 0.58 0.31
Book Value 9.10 7.53 6.31 5.28 22.04 78.22
Book Value(Adj)-Unit Curr 9.10 7.53 6.31 5.28 4.41 3.91

Shareholding Pattern

  • Promoter Group

    61.38%

  • Public Share Holding

    38.62%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 50,937,145 61.38 50,937,145 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 50,937,145 61.38 50,937,145 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 497,636 0.60 497,636 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,327 0.00 1,327 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 498,963 0.60 498,963 4
2] Non Institution
Bodies Corporate 3,369,041 4.06 3,368,641 63
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 436,961 0.53 436,961 134
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 876,532 1.06 875,732 1
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,956,043 5.97 4,956,043 26
Individuals holding nominal share capital up to Rs. 1 lakh 15,598,469 18.80 15,596,869 17,253
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,589,841 6.74 5,589,841 1
Others 0 0.00 0 221
Sub Total 31,547,892 38.02 31,545,092 17,706
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 82,984,000 100.00 82,981,200 17,716

Company Background

Medico Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Medico Remedies Ltd
  • BSE Code : 71781.0
  • ISIN : INE630Y01024

  • Incorporation Year

    1994

  • Registered Office

    1105/1106 11-Flr Hubtown Solar
    N S Phadke Marg Andheri East, Mumbai,
    Maharashtra-400069

  • Telephone

    91-22-2670 1055/66

  • FAX

  • Chairman

    Haresh Mehta

  • Managing Director

    Harshit Mehta

  • Company Secretary

    Vidhi Ankit Shah

  • Auditor

    Shah Shroff & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Medico Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Medico Remedies 18.82 212.31 206.38 11.34 23.23
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77